A Feasibility Study of ApricityOncology Digital Therapeutics for Management of Immune-Related Adverse Events in Patients on Immuno-Oncology Therapy
Sponsor: |
Apricity Health, LLC |
Enrolling: |
Male and Female Patients |
IRB Number: |
AAAS3665 |
Contact: |
Research Nurse Navigator: 212-342-5162 / cancerclinicaltrials@cumc.columbia.edu |
The purpose of this research study is to test how well a smartphone application (app), called ApricityCare, allows cancer patients being treated with immune-checkpoint therapy to monitor and report side effects to their oncology nurses and doctors. The app will also provide educational material to teach patients about side effects.
This study is closed
Investigator
Brian Henick, MD
Are you at least 18 years old? |
Yes |
No |
Have you been diagnosed with cancer? |
Yes |
No |
Do you own a smartphone? |
Yes |
No |
Are you comfortable with digital and/or mobile technology? |
Yes |
No |